IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
36.11
+0.05 (0.14%)
Oct 9, 2026, 4:00 PM EDT - Market closed
IDEAYA Biosciences Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, IDEAYA Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $52.75. The average 1-year stock price forecast is 46.08% higher than the current stock price, while the lowest is $31 (-14.15%) and the highest is $65 (+80.01%).
Price Target: $52.75 (+46.08%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for IDEAYA Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 13 | 11 | 11 | 11 | 10 | 10 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 16 | 15 | 15 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Maintains $58 | Buy | Maintains | $58 | +60.62% | Sep 27, 2026 |
| Citi | Citi | Buy Maintains $65 | Buy | Maintains | $65 | +80.01% | Sep 11, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $54 → $57 | Buy | Maintains | $54 → $57 | +57.85% | Sep 9, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $50 | Buy | Maintains | $50 | +38.47% | Sep 1, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 1, 2026 |
Financial Forecast
Revenue This Year
41.10M
from 218.71M
Decreased by -81.21%
Revenue Next Year
119.76M
from 41.10M
Increased by 191.41%
EPS This Year
-4.58
from -1.28
EPS Next Year
-4.01
from -4.58
EPS and Forward PE are based on non-GAAP adjusted numbers.